A trial date has yet to be set for Amgen Inc.’s G-CSF patent litigation with Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Following the August 13, 2010 hearing, on…
Teva Pharmaceuticals Inc. has withdrawn its appeal to a decision upholding the validity of Merck & Co. Inc.’s Singulair patent.
In February 2007, the Company received a notice from Teva Pharmaceuticals,…
No trial date has been set for Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged infringement of U.S. Patent Nos. 5,912,013 and 5,326,570.
Both patents relate to carbamazepine.
The…
A ruling on Merck & Co Inc.’s suit against Teva Pharmaceuticals Inc. in the U.S. District Court for the District of New Jersey for the alleged infringement of U.S. Patent…
A court date for the trial has yet to be scheduled for Novartis AG’s infringement lawsuits against generic manufacturers, including Teva Pharmaceuticals, to enforce the Company’s rights under the patent…
A 2010 trial is expected for Novartis AG’s infringement lawsuits against generic manufacturers, including Teva Pharmaceuticals, to enforce the Company’s rights under the patent covering Lotrel.
The Company is involved in…
Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged infringement of ADDERALL XR patents was settled on March 6, 2008.
In February 2005, the Company was notified that Teva…